What stocks benefit from the CDC vaccine contracts this week?

Merck ($MRK) and Pfizer ($PFE) are the direct beneficiaries with $2.0B and $769M contracts respectively. Both are strong buys for vaccine exposure.

How much revenue does the Merck contract add?

Merck's $2.0B contract represents about 3.3% of its annual revenue. Pfizer's $769M adds about 1.3%.

Which defense stocks are moving this week?

General Dynamics ($GD) won a $136M Stryker contract. KBR ($KBR) won a $227M NASA contract. Both are positive but smaller catalysts.

What is the Iran-US naval clash impact on oil stocks?

The macro override is bullish for energy and defense sectors but no specific stock tickers are directly named. Expect volatility in oil ETFs like $USO.

Weekly Briefing•October 28, 2026•4 min read

$2.8B in Federal Vaccine Contracts Just Dropped, 2 Stocks Positioned to Benefit

Merck ($MRK) and Pfizer ($PFE) secured $2.8B in CDC vaccine contracts for the Vaccines for Children program, boosting revenue visibility. Defense stocks like General Dynamics ($GD) and KBR ($KBR) also see tailwinds.

$MRK $PFE $GD +2 more

Key Takeaways

▸Merck ($MRK) secured a $2.0B CDC contract for the Vaccines for Children program, representing about 3.3% of its annual revenue.
▸Pfizer ($PFE) received a $769M CDC contract for the same program, adding roughly 1.3% to its top line.
▸General Dynamics ($GD) won a $136M Stryker retrofit kit contract, extending revenue visibility through 2030.
▸KBR ($KBR) landed a $227M NASA delivery order for human spaceflight health services, about 2.9% of annual revenue.
▸Combined $2.8B in vaccine contracts signals sustained federal commitment to childhood immunization, benefiting both $MRK and $PFE.

Congress just dropped a massive catalyst for healthcare investors: the CDC awarded $2.8 billion in new vaccine contracts to Merck ($MRK) and Pfizer ($PFE) for the Vaccines for Children program. These are not small orders. They are multi-year IDIQ contracts that provide predictable revenue streams.

For traders scanning for catalysts, this is a clear buy signal for vaccine-exposed stocks.

The Merck Contract: $2.0B Catalyst: Why $MRK Is Moving

Merck Sharp & Dohme LLC, a subsidiary of Merck & Co. ($MRK) received a $2.0B indefinite delivery/indefinite quantity contract from the CDC. This represents about 3.3% of Merck's annual revenue. The contract covers vaccines for children, reinforcing Merck's vaccine leadership.

The multi-year structure reduces earnings uncertainty for $MRK. Supply chain companies like Thermo Fisher ($TMO) and Sartorius () may also see increased orders for bioprocessing equipment.

Unlock the full analysis & 2 more tickers

The remaining 4 sections, full ticker list, charts, and FAQs are available to HillSignal members.

Already have an account? Log in

The Pfizer Contract: $769M Catalyst for $PFE

Pfizer ($PFE) secured a $769M IDIQ contract from the CDC for the same Vaccines for Children program. While modest relative to Pfizer's size, it adds 1.3% to annual revenue and signals continued government spending on public health. The contract aligns with legislative push for healthcare innovation, such as HR10857.

Investors can view this as a predictable cash flow component. Supply chain partners like Thermo Fisher ($TMO) may also benefit.

Chart: Vaccine Contract Values Compared

Vaccine Contract Values ($B)

Merck ($MRK)

Pfizer ($PFE)

0.769

GlaxoSmithKline

0.733

Sanofi

0.58

Contract Value ($B)

Defense Tailwinds: $GD and $KBR Also Benefit

Beyond healthcare, defense stocks are moving. General Dynamics ($GD) received a $136M Stryker retrofit contract, adding to cumulative $162.4M. This is a small but positive signal for GD's Combat Systems segment.

KBR ($KBR) secured a $227M NASA delivery order for human spaceflight health services, about 2.9% of annual revenue. Both contracts provide multi-year revenue visibility through 2030 and 2025 respectively. Legislative tailwinds from Ukraine defense transfers (HR10912) may drive further demand for $GD.

What Traders Should Watch Next

For vaccine stocks, monitor future obligations under these IDIQ contracts to gauge full revenue potential. For defense, watch for follow-on orders and supply chain contracts from the Air Force $5.4B adversary air program. The macro overrides like Iran-US naval clash could disrupt oil supply chains, but direct stock impact is limited.

Focus on the clear catalysts: $MRK and $PFE are the strongest signals this week.

Disclaimer: This content is for informational purposes only and does not constitute financial advice. Always do your own research before making investment decisions.

Found this useful? Share it.